Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-28

Clinical Trial Update: Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating topical epigallocatechin gallate (green tea extract) for radio dermatitis and radiation mucositis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epigallocatechin Gallate (epigallocatechin gallate)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Epigallocatechin Gallate, Radio Dermatitis | Phase 1, Phase 2 | Status: UNKNOWN